{"status":"OK","data":{"advertisement":{"id":390147,"title":"REQUEST FOR QUOTATION No. 08 10 2026 AT","partial_offer_allowed":false,"publication_date":"2026-10-08","submission_deadline":"2026-10-15 23:59:59","planned_sign_date":"2026-10-01","supplementary_orders":null,"terms_of_contract_change":"Warunki zmiany umowy zosta\u0142y zamieszone w za\u0142\u0105czonym zapytaniu ofertowym w wersji PDF.\nThe terms and conditions of the contract amendment are set out in the attached PDF version of the RFQ.","created_at":"2026-10-08 17:23:16","modified_at":"2026-10-16 00:00:28","contact_persons":[{"id":57,"forename":"Aleksandra","surname":"Mazga\u0142a","phone_number":"+48 538 899 945","email":"tenders@ryvu.com","created_by":null,"created_at":"2026-11-06 17:43:17","modified_at":"2026-11-06 17:43:17","modified_by":null}],"orders":[{"id":631988,"estimated_value":null,"order_items":[{"id":710719,"description":"Celem post\u0119powania jest wyb\u00f3r dostawcy zdolnego do \u015bwiadczenia kompleksowej us\u0142ugi obejmuj\u0105cej wykonanie testu \u017cywotno\u015bci kom\u00f3rek metod\u0105 2D opart\u0105 na ilo\u015bciowym oznaczaniu ATP z odczytem luminescencyjnym, na indywidualnie dobranym panelu linii kom\u00f3rek nowotworowych (w tym wariant\u00f3w opornych na leki, uzyskanych metodami indukowania oporno\u015bci in vitro oraz edycji genetycznej), dla zwi\u0105zk\u00f3w typu payload/ADC dostarczonych przez Ryvu. Zakres us\u0142ugi obejmuje 5-dniow\u0105 inkubacj\u0119, 10-punktow\u0105 krzyw\u0105 zale\u017cno\u015bci odpowiedzi od st\u0119\u017cenia, wyznaczenie warto\u015bci EC\u2085\u2080 oraz pomiar T0 dla ka\u017cdej linii kom\u00f3rkowej, przy czym wszystkie badania maj\u0105 by\u0107 wykonywane w trzech powt\u00f3rzeniach (triplikatach).\nPe\u0142ny opis przedmiotu zam\u00f3wienia znajduje si\u0119 w za\u0142\u0105czonym zapytaniu ofertowym w wersji PDF.\n\nThe objective is to select a vendor capable of providing a consolidated service that includes a 2D luminescence-based ATP-quantification cell viability assay performed on a custom-selected panel of cancer cell lines (including drug-resistant variants generated by in vitro drug-induced resistance and genetic editing methods) for payload/ADC compounds provided by Ryvu, incorporating a 5-day incubation, a 10-point concentration\u2013response curve, EC\u2085\u2080 determination, and T0 measurement for each cell line, with all testing conducted in triplicate. \nA full description of the subject of the contract is provided in the attached request for quotation in PDF version.","warranty_period":null,"cpv_items":[{"id":8515,"code":"73111000-3","name":"Laboratoryjne us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":null,"id":810023,"type":{"id":1,"name":"adres"},"group_uuid":"eaf8d982-859f-4068-914d-8f99871dec49"}],"participation_conditions":[{"id":2034383,"description":"Pe\u0142na lista warunk\u00f3w udzia\u0142u w post\u0119powaniu znajduj\u0119 si\u0119 w za\u0142\u0105czonym zapytaniu ofertowym w wersji PDF.\nThe full list of conditions for participation in the proceedings can be found in the attached PDF version of the request for quotation.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":null,"group_uuid":"1da2aa64-5d8d-4610-865a-12ebbea514b3"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":null,"group_uuid":"3e5797b5-967c-4e6c-bee7-69cdf7d1a400"}],"evaluation_criteria":[{"id":1140043,"price_criterion":true,"description":"Cena netto (\"C\") - 10.00 pkt.\nPrice Net (\"C\") \u2013 10.00 points","created_by":null,"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":null,"group_uuid":"9c0538b6-47d4-477f-9668-687ec98fe857"}],"is_variant":false,"title":"1","order_node":{"id":476041},"created_by":null,"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":{"id":112,"contact_persons":[]},"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":{"id":112,"contact_persons":[]},"id":1107634,"street":"Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2026-10-08 17:23:16","modified_at":"2026-10-08 17:23:16","modified_by":{"id":112,"contact_persons":[]},"id":391226},"advertisement":{"id":294314,"number":"2026-112-294314","publication_date":"2026-10-08","created_by":{"id":112,"contact_persons":[]},"created_at":"2026-10-08 17:20:37","modified_at":"2026-10-16 00:00:28","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[390146,390147],"enrollment":{"id":74222,"name":"DUALIS","number":"001/26","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-001/26","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2026-08-11 18:44:41","modified_at":"2026-08-11 18:44:41","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":390147,"publication_date":"2026-10-08"},"id":2817595,"name":"RFQ 08 10 2026 AT.pdf","file":{"id":3127040,"name":"RFQ 08 10 2026 AT.pdf","created_at":"2026-10-08 17:23:08","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/3127040"},"group_uuid":"5546693c-aef1-4111-bef7-e96ddb70a6c1"},{"origin":{"id":390147,"publication_date":"2026-10-08"},"id":2817596,"name":"Offer Form 08 10 2026 AT.docx","file":{"id":3127041,"name":"Offer Form 08 10 2026 AT.docx","created_at":"2026-10-08 17:23:12","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/3127041"},"group_uuid":"87041488-2ee9-466f-a979-2bb232554595"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}